Related Experiment Video
Updated: Jun 27, 2026

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
Published on: October 12, 2018
Human immunodeficiency virus per se exerts atherogenic effects
Ugo Oliviero1, Giovanni Bonadies, Valentina Apuzzi
1Department of Internal Medicine, University Federico II, Naples, Italy.
Insights
Human Immunodeficiency Virus (HIV) infection causes early vascular damage, including thickened carotid arteries and impaired blood vessel function, independent of treatment or metabolic issues. This suggests HIV itself contributes to atherosclerosis development.
Area of Science:
- Cardiovascular Medicine
- Infectious Diseases
- Vascular Biology
Background:
- Premature atherosclerosis in HIV patients is often linked to highly active antiretroviral therapy (HAART) and metabolic complications.
- The independent role of Human Immunodeficiency Virus (HIV) infection in promoting atherosclerosis remains unclear.
- This study investigates whether HIV infection itself contributes to atherogenic effects.
Purpose of the Study:
- To determine if HIV infection per se induces atherogenic vascular changes.
- To evaluate the impact of HIV on vascular structure and function in treatment-naïve patients.
Main Methods:
- Carotid intima-media thickness (IMT) and brachial artery vasodilation (flow-mediated dilation [FMD] and non-dependent vasodilation [NMD]) were measured.
- 38 treatment-naïve, untreated HIV-infected patients and 41 healthy controls were studied.
- Controls were matched for metabolic risk factors.
Main Results:
- HIV patients exhibited significantly higher mean carotid IMT compared to controls (0.85±0.2mm vs. 0.63±0.1mm).
- Carotid IMT was associated with duration of HIV infection and CD4 T-cell count.
- Brachial FMD was significantly impaired in HIV patients (8.8±3% vs. 12.2±3% in controls), correlating inversely with HIV viral load (HIV-RNA copies).
- NMD did not differ significantly between groups.
Conclusions:
- HIV infection causes early functional and structural vascular alterations, independent of HAART and metabolic factors.
- Findings support the theory that viral infection contributes to atherosclerosis.
- Early vascular assessment in HIV-infected patients is recommended.
Objective:
Premature atherosclerosis in HIV-infected patients has been attributed to highly active antiretroviral therapy (HAART) and the associated metabolic complications. Whether HIV per se plays a role is an unresolved issue. The purpose of this study was to evaluate whether HIV per se exerts atherogenic effects.
Methods:
We measured carotid intima-media thickness (IMT) and brachial endothelial-dependent (FMD) and endothelial-independent (NMD) vasodilation in 38 naïve untreated HIV-infected patients and 41 healthy control subjects.
Results:
Control subjects were selected as to match the HIV patients for metabolic risk factors. Mean carotid IMT was higher in HIV patients (0.85+/-0.2mm; p<0.001) than in controls (0.63+/-0.1mm). In a stepwise multiple regression model, the changes in carotid IMT were predicted by the duration of HIV infection (p<0.001) and CD4 T-cells (p=0.035). Brachial FMD was impaired in HIV patients (8.8+/-3% versus 12.2+/-3% in controls; p<0.001). In contrast, NMD values practically overlapped in the HIV patients and controls. Analysis of the data in relation to viral load showed that FMD was significantly more impaired in the subgroup of patients with viral load values above the median (p<0.001). In addition, there was a highly significant, inverse correlation between FMD and the HIV-RNA copies (p<0.001).
Conclusion:
HIV infection causes functional and structural vascular alterations in a very early stage of the infection independent of HAART and metabolic factors. The data lend support to the viral infectious theory of atherosclerosis. Early assessment of the vascular status in HIV-infected patients is suggested.
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Sexually Transmitted Infections
Inhibitors of Virion Maturation and Assembly

